- Home
- Articles
- latamerica
- tumor cell therapy
Tumor Cell Therapy Articles & Analysis
20 articles found
Among various delivery systems, lentiviruses have garnered significant attention due to their ability to introduce genetic material into both dividing and non-dividing cells, making them an ideal vehicle for gene therapy applications. Understanding CRISPR/Cas9 Technology CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) coupled with Cas9 ...
The BCL2 gene, short for B-cell lymphoma 2, is a critical regulator of apoptosis, or programmed cell death. ...
This phenomenon offers a remarkable opportunity in cancer therapy. Tumors often exhibit mutations that can be exploited for targeted treatments. ...
Alfa Cytology employs state-of-the-art techniques including isolation, culture, engineering, expansion, and characterization of immune cells and stem cells to develop novel cell therapies. These innovative solutions are grounded in a comprehensive understanding of tumor biology and immune system dynamics, ...
By harnessing the natural capabilities of the immune system, immuno-oncology services are revolutionizing the way we approach cancer treatment, offering novel therapies that are changing the prognosis for many patients. Understanding Immuno-Oncology Immuno-oncology focuses on the interaction between the immune system and cancer cells. Unlike traditional cancer ...
Cell cycle progression is orchestrated by key proteins, including cyclins, cyclin-dependent kinases (CDKs), and tumor suppressors. ...
Cell Analysis for Brain Tumors Cell analysis, particularly at the single-cell level, provides deep insights into the cellular heterogeneity within brain tumors. ...
Through peptide sequencing, we can discover new peptide drugs with specific bioactivity, such as peptide hormones and peptide antibodies, providing powerful tools for targeted therapy. At present, peptide drugs have shown broad application prospects in the treatment of tumors, hepatitis, diabetes, and AIDS.Antibody-Based TherapyAntibodies are proteins produced by ...
This cutting-edge technology holds great potential in treating diseases through targeted drug delivery. CAR-T/CAR-NK Cells Development for Drug Delivery Systems As a groundbreaking advancement in immunotherapy, CAR-T (Chimeric Antigen Receptor T-cell) and CAR-NK (Chimeric Antigen Receptor Natural Killer) cells have shown remarkable success in ...
What is CAR T-cell therapy? Car-t cell therapy involves genetically engineering T cells isolated from patients or allogeneic donors to express chimeric antigen receptors (CAR) that specifically recognize and kill tumor cells. As a "living" drug, CAR-T therapy ...
In hematological malignancies, complete response rates to CAR-T cells can exceed 80%. These responses are often durable in nature and have attracted considerable excitement and investment in the development of cell therapies for an expanded range of indications, particularly in solid tumors. The continued progress of ...
Chimeric antigen receptor T cells (CAR-T) and T cell antigen receptor chimeric T cells (TCR-T) are currently the "top stream" in adoptive T cell tumor immunotherapy. ...
CARs are able to recognize targets on the surface of tumor cells. Although CAR-T therapy has revolutionized the treatment of hematological diseases such as leukemia and lymphoma, it has not translated into similar success in solid tumors. ...
At present, chimeric antigen receptor T cell therapy (CAR-T) has made significant achievements in the treatment of specific hematological cancers, allowing patients with relapsed/refractory disease to survive longer and become healthier, but in clinical studies, cell therapy has actually not been successful in the treatment of ...
Aberrant glycosylation is a common hallmark of many malignancies and is important at all stages of tumor growth. Glycosylation regulates a range of physiopathological processes, including cell-cell adhesion, cell-matrix interactions, epithelial-mesenchymal transition, tumor proliferation, invasion, metastasis, ...
Adoptive cell transfer (ACT) therapy is one of the most effective therapeutic options for tumor immunotherapy that is currently emerging in clusters. ...
Normal cells have quality-control mechanisms to ensure that mRNA is correctly transcribed from gene-coding regions in DNA, but tumor cells make frequent transcription mistakes, including adding or cutting out nucleotides to produce mRNA riddled with errors called frameshift mutations. ...
ByCalviri
Why do we need new cell contenders in the CAR field? Well, different CAR immune cells have different advantages and sometimes unique challenges or limitations. So, we began our discussion of alternative CAR-cell types with CAR-NK cells due to their current standing as the most popular alternative CAR-based ...
Nanotechnology has entered the field of medicine in recent dacades and especially, in drug delivery systems, nanoparticles have shown an ability to improve pharmacokinetics, pharmacodynamics, efficacy and to reduce the toxicity of associated drugs. In this study, we have designed a new protoporphyrin-conjugated gold nanoparticle to selectively target and photo- or sonodynamic therapy of tumoural ...
The proton beam was investigated for cancer cell therapy in the pancreas. Neon ion interaction profiles were compared with the result of the proton beam, which was investigated for nanoscale ion beam interactions. Simulation for the Bragg peak calculation was performed for interactions with a human organ, the pancreas. The results show the absorbed dose and dose equivalent, which vary with the ...